ImmuCell
ICCC
27 hedge funds and large institutions have $6.21M invested in ImmuCell in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 0 closing their positions.
46% more capital invested
Capital invested by funds: $4.27M → $6.21M (+$1.94M)
23% more funds holding
Funds holding: 22 → 27 (+5)
1.21% less ownership
Funds ownership: 14.74% → 13.53% (-1.2%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$116K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$59.7K |
| 3 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$48.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$526K |
| 2 |
Renaissance Technologies
New York
|
-$49.8K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$25.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$13.4K |
| 5 |
SRC
Shufro Rose & Co
New York
|
-$5.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $57 | – | – | – |
|
27
Wells Fargo
San Francisco,
California
| $4 | – | – | – |
|
ICCC Hedge Fund Activity: Q4 2024 in Review
27 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2024, worth a combined $6.21M — up 46% from $4.27M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ICCC positions and 0 closed out — a net gain of 5 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $116K. The largest seller was Cresset Asset Management, cutting an estimated $526K.
- 27 institutional investors held ImmuCell (ICCC) as of Q4 2024, up from 22 in Q3 2024.
- Funds reported $6.21M of ImmuCell stock for Q4 2024, up 46% quarter-over-quarter.
- 5 funds opened new ImmuCell positions in Q4 2024 and 0 closed out, a net change of +5 holders.
- The largest ImmuCell buyer in Q4 2024 was Citadel Advisors, an estimated $116K added.
- The largest ImmuCell seller in Q4 2024 was Cresset Asset Management, an estimated $526K sold.
Based on aggregated 13F filings for Q4 2024.